Medytox's 'Newramis Volume Lidocaine' Receives Product Approval in China
"Targeting Launch in the Fourth Quarter"
Medytox announced on September 28 that it has received product approval for its hyaluronic acid filler, 'Newramis Volume Lidocaine', from the National Medical Products Administration (NMPA) of China.
In addition to 'Newramis Deep Lidocaine', which has already been approved in China, Medytox has now added 'Newramis Volume Lidocaine', expanding its product lineup to a total of two hyaluronic acid fillers. 'Newramis' will be sold in China under the brand name 'Fillux'.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Medytox representative stated, "We plan to expand our local, customized product portfolio, proceed with follow-up procedures through close cooperation with our partner company, and continue our global growth momentum with the goal of launching in the fourth quarter."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.